Apixaban in Acute Coronary SyndromesKARTHIKEYAN, Ganesan; EIKELBOOM, John W.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 5, pp 285-290, issn 1755-5914, 6 p.Article

Management of patients with acute coronary syndromes: What is the clinical role of direct thrombin inhibitors?EIKELBOOM, John W; FRENCH, John.Drugs (Basel). 2002, Vol 62, Num 13, pp 1839-1852, issn 0012-6667, 14 p.Article

The CHADS₂ score for stroke risk stratification in atrial fibrillation -friend or foe?KARTHIKEYAN, Ganesan; EIKELBOOM, John W.Thrombosis and haemostasis. 2010, Vol 104, Num 1, pp 45-48, issn 0340-6245, 4 p.Article

CYP2C19 Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary InterventionPARE, Guillaume; EIKELBOOM, John W.Circulation. Cardiovascular interventions. 2011, Vol 4, Num 5, pp 514-521, issn 1941-7640, 8 p.Article

Monitoring unfractionated heparin with the aPTT : Time for a fresh look : Laboratory methods in the haemostatic laboratoryEIKELBOOM, John W; HIRSH, Jack.Thrombosis and haemostasis. 2006, Vol 96, Num 5, pp 547-552, issn 0340-6245, 6 p.Article

Management of antiphospholipid antibody syndrome : A systematic reviewLIM, Wendy; CROWTHER, Mark A; EIKELBOOM, John W et al.JAMA, the journal of the American Medical Association. 2006, Vol 295, Num 9, pp 1050-1057, issn 0098-7484, 8 p.Article

Folic acid-based multivitamin therapy to prevent stroke: The jury is still outHANKEY, Graeme J; EIKELBOOM, John W.Stroke (1970). 2004, Vol 35, Num 8, pp 1995-1998, issn 0039-2499, 4 p.Article

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: A meta-analysis of randomized, controlled trialsQUINLAN, Daniel J; MCQUILLAN, Andrew; EIKELBOOM, John W et al.Annals of internal medicine. 2004, Vol 140, Num 3, pp 175-183, issn 0003-4819, 9 p.Article

Dabigatran Etexilate: A New Oral Thrombin InhibitorHANKEY, Graeme J; EIKELBOOM, John W.Circulation (New York, N.Y.). 2011, Vol 123, Num 13, pp 1436-1450, issn 0009-7322, 15 p.Article

Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention TrialsEIKELBOOM, John W; QUINLAN, Daniel J; O'DONNELL, Martin et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 20, pp 2006-2011, issn 0009-7322, 6 p.Article

Effect of fondaparinux 2.5 mg once daily on mortality : a meta-analysis of phase III randomized trials of venous thromboembolism preventionEIKELBOOM, John W.European heart journal supplements. 2008, Vol 10, Num C, issn 1520-765X, C8-C13Article

Beyond unfractionated heparin and warfarin : Current and future advancesHIRSH, Jack; O'DONNELL, Martin; EIKELBOOM, John W et al.Circulation (New York, N.Y.). 2007, Vol 116, Num 5, pp 552-560, issn 0009-7322, 9 p.Article

Aspirin resistanceHANKEY, Graeme J; EIKELBOOM, John W.Lancet (British edition). 2006, Vol 367, Num 9510, pp 606-617, issn 0140-6736, 12 p.Article

Low molecular weight heparins and heparinoidsEIKELBOOM, John W; HANKEY, Graeme J.Medical journal of Australia. 2002, Vol 177, Num 7, pp 379-383, issn 0025-729XArticle

Adding aspirin to clopidogrel after TIA and ischemic stroke : Benefits do not match risksHANKEY, Graeme J; EIKELBOOM, John W.Neurology. 2005, Vol 64, Num 7, pp 1117-1121, issn 0028-3878, 5 p.Article

Cyclooxygenase-2 inhibitors: Are they really atherothrombotic, and if not, why not?HANKEY, Graeme J; EIKELBOOM, John W.Stroke (1970). 2003, Vol 34, Num 11, pp 2736-2740, issn 0039-2499, 5 p.Article

Recurrent palmar-plantar erythrodysaesthesia following high-dose cytarabine treatment for acute lymphoblastic leukemiaCRAWFORD, Julie H; EIKELBOOM, John W; MCQUILLAN, Andrew et al.European journal of haematology. 2002, Vol 69, Num 5-6, pp 315-317, issn 0902-4441, 3 p.Article

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention : A randomized controlled trialEIKELBOOM, John W; O'DONNELL, Martin.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 1, issn 0098-7484, 43-51,91-92 [11 p.]Article

Antiplatelet drugsHANKEY, Graeme J; EIKELBOOM, John W.Medical journal of Australia. 2003, Vol 178, Num 11, pp 568-574, issn 0025-729X, 7 p.Article

Coagulation Factor IXa as a Target for Treatment and Prophylaxis of Venous ThromboembolismEIKELBOOM, John W; ZELENKOFSKE, Steven L; RUSCONI, Christopher P et al.Arteriosclerosis, thrombosis, and vascular biology. 2010, Vol 30, Num 3, pp 382-387, issn 1079-5642, 6 p.Article

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement : a meta-analysis of the randomised trialsEIKELBOOM, John W; QUINLAN, Daniel J; DOUKETIS, James D et al.Lancet (British edition). 2001, Vol 358, Num 9275, pp 9-15, issn 0140-6736Article

Venous thromboembolism in travellers: can we identify those at risk?MCQUILLAN, Andrew D; EIKELBOOM, John W; BAKER, Ross I et al.Blood coagulation & fibrinolysis. 2003, Vol 14, Num 7, pp 671-675, issn 0957-5235, 5 p.Article

Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials : Coagulation proteases and cardiovascular diseaseVANASSCHE, Thomas; HIRSH, Jack; EIKELBOOM, John W et al.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 918-923, issn 0340-6245, 6 p.Article

Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trialsPAIKIN, Jeremy S; WRIGHT, Doug S; EIKELBOOM, John W et al.Blood reviews. 2011, Vol 25, Num 3, pp 123-129, issn 0268-960X, 7 p.Article

Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke : A Critical ReviewO'DONNELL, Martin J; HANKEY, Graeme J; EIKELBOOM, John W et al.Stroke (1970). 2008, Vol 39, Num 5, pp 1638-1646, issn 0039-2499, 9 p.Article